Drug class | Baseline N (%) | Study end N (%) | P* |
---|---|---|---|
Anti-platelet | 3 (4.7%) | 43 (68.3%) | < 0.001 |
Lipid lowering | 4 (6.3%) | 41 (65.1%) | < 0.001 |
ACEi/ARB | 16 (25%) | 40 (63.5%) | < 0.001 |
Oral hypoglycaemic | 11 (17.2%) | 21 (33.3%) | 0.04 |
Beta blocker | 3 (4.7%) | 8 (12.7%) | 0.09 |
Nitrate | 2 (3.1%) | 3 (4.8%) | 0.49 |
Thiazide diuretic | 0 | 2 (3.2%) | 0.24 |
Calcium channel blocker | 1 (1.6%) | 1 (1.6%) | 0.75 |